What is Vericel's number of commercial-stage products?

Vericel (VCEL) reported number of commercial-stage products of 3 in Q1 2026.

How has Vericel's number of commercial-stage products changed year-over-year?

Vericel's number of commercial-stage products decreased by 0.0% year-over-year, from 3 to 3.

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Market cap$2.13B-26.8%

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Reported directly by Vericel in its filing.

Tagged under the XBRL concept vcel:NumberOfProducts.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

What is Vericel's number of commercial-stage products?: Vericel (VCEL) reported number of commercial-stage products of 3 in Q1 2026.
How has Vericel's number of commercial-stage products changed year-over-year?: Vericel's number of commercial-stage products decreased by 0.0% year-over-year, from 3 to 3.